Zoom is a video conferencing app, geared towards business usage. It was founded in 2011 by Eric Yuan, and launched in January 2013. While gathering considerable popularity and coming to run profitably ...

SAR-446422 is under clinical development by Sanofi and currently in Phase I for Inflammation. According to GlobalData, Phase I drugs for Inflammation have a 44% phase transition success rate (PTSR) ...

Sanofi's participation at the JP Morgan 43rd Annual Healthcare Conference on 14 January 2025 was marked by a comprehensive overview of the company's position in 2024 and its strategic vision for t ...

The use of Sanofi’s Dupixent in atopic dermatitis has set a high benchmark for competitors within the space. Credit: marishkaSm via Shutterstock. Sanofi’s participation at the JP Morgan 43rd Annual ...

Adding one of these travel photos as your Zoom background takes way less time than getting through customs. Here's how it's done. Make sure you have Zoom virtual backgrounds enabled on your Zoom ...

We list the best Zoom alternatives ... and you can enhance meetings with presentations, emojis, background noise removal, and real-time translation. Webex works with more than 100 third-party ...

Get up close and personal with distant subjects with our pick of the best zoom cameras you can buy right now Although the smartphone in your pocket can do a lot of great things - including taking ...

Sanofi’s Q3 revenue grew by 12.3% to €13.438 billion, driven by products like Dupixent and influenza vaccines. Dupixent remains a top growth driver, with potential peak sales exceeding $20 ...

Snapshot of the implementation used to generate figures and numerical results from the paper "Sharp Bounds for Continuous-Valued Treatment Effects with Unobserved ...

Sanofi has tapped Alloy Therapeutics to enable development of a central nervous system drug, agreeing to pay $27.5 million in upfront and near-term fees to access an antisense platform. Alloy is ...

The companies have teamed up to use Alloy’s AntiClastic Antisense platform. Credit: Bevan Goldswain via Getty Images. Sanofi has entered into a collaboration and license agreement with Alloy ...

The Company has received communication from its Registrar and Share Transfer Agent on loss of share certificates. Kindly refer to the enclosed file for details. The Company has approved issue of ...